AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Former Mossad chief and real estate tycoons back controversial Israeli drone company
3
Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”
4
Oasis Security raises $120 million Series B to secure the rise of AI agents
5
Israel’s war with Iran costs up to $550 million a day
More news

EpiPen

4 stories about EpiPen
מטה חברת טבע תרופות

Teva Jumps on NYSE on a Bit of Good News

21.08.19|Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
תרופה מזרק אפיפן מיילן אלרגיה

Teva, Mylan Drop on Announcement of Epinephrine Injector Rival

09.12.18|Lilach Baumer
Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300
תרופה מזרק אפיפן מיילן אלרגיה

Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers

28.11.18|Lilach Baumer
In August, the Israel-headquartered drugmaker won approval to market the first generic EpiPen auto-injectors in the U.S.
תלמידים כיתה בית ספר לימודים ילדים

Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

26.08.18|Dror Reich
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month